This paper argues that surrogate models can be used in legacy systems because they are provable, implementable and certifiable with respect to the future development assurance guidance for ML applications anticipated by the European union Aviation Safety Agency (EASA).
Gabreau et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: